TET2 mutations are also frequent in B-cell malignancies, particularly in diffuse large B-cell lymphoma (DLBCL; 6~12%), the most common type of non-Hodgkin’s lymphoma arising from germinal center B cells. This evidence concerns the gene TET2 and diffuse large B-cell lymphoma.